Navigation Links
Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer

GSK Announces Launch of Largest Ever Phase III Clinical Trial in Lung Cancer Treatment

PHILADELPHIA, June 05, 2007 /PRNewswire-FirstCall/ -- GlaxoSmithKline today announced final results of a Phase II proof-of-concept clinical trial of its investigational MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) in MAGE-A3 positive patients with stage IB or II Non-Small Cell Lung Cancer (NSCLC). These data were presented at the 2007 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Illinois, [Abstract No: 7554]. Final trial analysis showed a 27% reduction in the relative risk of cancer recurrence following surgery in patients treated with the MAGE-A3 ASCI, compared to placebo.

"Final results from this trial confirm the positive interim results released last year at ASCO 2006, and support expanded testing of this novel cancer immunotherapy," said Paul A. Bunn Jr., M.D., James Dudley Endowed Professor of Oncology, Professor of Medicine and Director of the University of Colorado Cancer Center, Aurora, Colorado. "This approach represents a potentially momentous shift in the cancer treatment paradigm. I believe we have only just scratched the surface of what is possible and look forward to seeing the results of the Phase III trial in due course."

Based on these encouraging data, GSK also announced today the opening of patient recruitment to the randomized and controlled Phase III efficacy and safety trial for this novel cancer immunotherapy; the largest clinical trial ever conducted in lung cancer treatment. MAGE-A3 ASCI will be evaluated as adjuvant therapy in about 2,270 MAGE-A3 positive patients with completely resected stage IB, II or IIIA NSCLC.

GSK's ASCIs aim to stimulate the patient's own immune response to identify and attack cancer cells in a highly specific manner. This novel cancer immunotherapy is developed using tumor specific antigens, delivered as highly puri
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
2. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
3. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
4. Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
5. Genetic Analysis Systems Enter the Clinical Mainstream
6. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
7. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
8. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease

Post Your Comments:
(Date:11/6/2009)...l/ -- NuVasive, Inc. (Nasdaq: NUVA ), a medical d...inimally disruptive surgical treatments for the sp... Lambert as Executive Vice President and Chief Fin...ompany also announced several other Executive Mana...ellent complement to the NuVasive family," said Al...
(Date:11/6/2009)...-- Philips Respironics applauds the efforts of the...to raise awareness about an important public healt...release of the first-ever government study to moni... a milestone in quantifying the size and scope of ...try leader and sleep therapy manufacturer, Philips...
(Date:11/6/2009).../ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX...r 10, 2009 at 8:30 a.m. EST to discuss the third q... for the remainder of 2009. Ron Bentsur, Chief Ex.... Keryx will announce its financial results for t...o the call. ,, In order to participate in the c...
Breaking Medicine Technology:NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Nick Jonas of the Jonas Brothers to Address the National Press Club on August 24 53272 1Nick Jonas of the Jonas Brothers to Address the National Press Club on August 24 53272 2Tevas Forum Draws Key Pennsylvania Healthcare Leaders 53270 1Tevas Forum Draws Key Pennsylvania Healthcare Leaders 53270 2Judge Sues Blue Cross for Autism Treatment 53268 1Judge Sues Blue Cross for Autism Treatment 53268 2
(Date:11/8/2009)...ILADELPHIA, Nov. 8 The ... the prevention and wellness provisions in the hea..., "With passage of this bill, the House takes im...g important insurance reforms and moving our healt...k to one that focuses on keeping people healthy," ...
(Date:11/8/2009)... pain now can take you out of the game later, doct...ws) -- Foot injuries are the talk of the NFL this ...anning and running back Willie Parker. , Offici...and American Academy of Podiatric Sports Medicine ...en they play fall sports like football and lacross...
(Date:11/8/2009)... New book called "Preventing... by Dr. Roberto Giraldo shows that AIDS is a resul...variety of so-called immune system stressor agents...nal and most of all, emotional. , ...From Nov. 6 – 8, 2009, cell biologists, phys...
(Date:11/8/2009)... A jury of 8 people in the Wester...woman $2,300,000 in pain and suffering for a medic...mes Tallman and Alicia Nocera of Thomas E. Crenney... the plaintiff, Vita Monestersky and against the U...ency total abdominal hysterectomy at age 18. , ...
(Date:11/8/2009)...SHINGTON, Nov. 7 USActi...ealth Care for America Act, which will make health...e companies accountable and increase access to hea...c option. ,, "Teddy Roosevelt, FDR and Harry Tr...or Alan Charney. "Today,s vote ranks among our cou...
Breaking Medicine News(10 mins):Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Rx for Fall Foot Injuries 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2
Shiv Sena on Sunday strongly reacted to the recent Union Health Ministry notice to yoga guru Baba Ramdev,// saying the government is compromising national interests in connivance with multinational c
...cas County health department has reported that a S...ering meningitis// and was admitted to a hospital ...nabled the dates during which the Santa was workin...has advised all children who may have interacted w...
...deh, 30, Muir Beach, CA, was living day-to-day, ex...shortened life dependent// on kidney dialysis. She...donor” antibody levels were so high, her doctors b...inai Medical Center, Soraya successfully underwent...
... Lacks to Meet Inmates' Basic Health Needs – a Rep...s of at least 14 inmates since 1999 in the nation'...errors and other breakdowns in their medical care.... investigation by the Los Angeles Times found that...
...nish physician is to examine ailing Cuban leader F...alunya reported on Sunday.// Jose Luis Garcia...of the country's government. The doctor from Madri...is to give Castro a thorough examination and advis...
...e Institute Pasteur has recently shown that the tu...n its host's fat cells. //This formidable pathogen...iotics in these cells, in which it may remain dorm...e bacillus entirely from infected individuals shou...
Other Medicine News:Health News:Anti-rejection Therapy a Boon for Patients With "anti-donor" Antibody Levels 2Health News:Anti-rejection Therapy a Boon for Patients With "anti-donor" Antibody Levels 3Health News:Anti-rejection Therapy a Boon for Patients With "anti-donor" Antibody Levels 4Health News:Health Care Suffers at Los Angeles Jails: Report 2Health News:Tuberculosis: The Bacillus Takes Refuge in Adipose Cells 2
The Natural-Knee Unicompartmental System
Advance Uni-Comparental Knee Components - Uni All-poly Tibial Component
Maxim®
...is a complete range of interchangeable, anatomical...clinical results. The Natural-Knee design includes...ry CSTi porous coating option for stable fixation ...rior stabilizing design, a deepened trochlear groo...
Medicine Products: